1182.58.44004 Boehringer Ingelheim Investigational Site

Brighton

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection — APPROVED_FOR_MARKETING